Who We Are
How can we do more for our patients?
Everything at Takeda starts with this question.
Positions & Guidelines
Risk & Crisis Management
Global Ethics & Compliance
From the CEO
We have global presence in more than 70 countries.
What We Do
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Research & Development
Ecosystem for Health Innovation
Takeda Clinical Trial Transparency
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Alliances & Partnerships
Access to Medicines
Supplier Code of Conduct
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
We focus on our core therapeutic areas.
Find out Takeda's stories related on Innovation, Caring and Heritage
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
An Empowered Women-led Workforce
Keys to Aging Gracefully
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
Basic Policies on CSR
Corporate Citizenship Activities
Global CSR Program
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
Takeda is working to resolve global healthcare issues with people around the world.
In the News
Last 12 months
July 21, 2017
Takeda and Schrödinger Announce Multi-year, Multi-Target Research Collaboration
July 11, 2017
Takeda prices US$500 million senior note offering
July 10, 2017
Takeda Announces the Start of Operations for AXCELEAD at its Shonan Research Center
June 30, 2017
Takeda Announces Selection of Global CSR Programs Emphasizing Prevention for Health in Developing and Emerging Countries
June 29, 2017
Takeda Submits a New Drug Application for Rasagiline Mesylate for the Treatment of Parkinson’s Disease in Japan
June 27, 2017
Takeda Announces New Assignments of Directors
June 26, 2017
June 26, 2017
Takeda and Biological E. Limited Announce Partnership to Develop Low-Cost Combination Vaccines for Low- and Middle-Income Countries around the Globe
June 23, 2017
Phase 1/2 NINLARO data at EHA
Copyright 1995-2017 Takeda Pharmaceutical Company Limited. All rights reserved.